Metreleptin in Anorexia Nervosa — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Metreleptin in Anorexia Nervosa — Stella

Home/Anorexia Nervosa/

View on ClinicalTrials.gov

Recruiting

Back to Anorexia Nervosa trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Switzerland

Eating Disorder Unit, Clinic of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, Zurich, Canton of Zurich

Key details

Phase

Safety & dosing

Sponsor

Gabriella Milos

Enrollment target

~50 participants

Started

May 2024

Primary completion

August 2026

Age range

17 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.